CD4 and viral infectious disease: In addition, the WHO advises starting highly active antiretroviral therapy (HAART) in HIV patients who are also coinfected with HBV or HCV regardless of their CD4 T lymphocyte count; however, the regimen to use depends on which of these viral infections is present because failing to do so could put the patient at higher risk for hepatotoxicity [5].